Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma [Phase 2]
This update reports results from a Phase II trial evaluating sequential chemotherapy followed by radiotherapy for AIDS-related primary centr…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL) [Phase 2]
A Phase 2 randomized study comparing Iodine-131 labeled anti-B1 antibody to unlabeled anti-B1 antibody in chemotherapy-relapsed/refractory l…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of bortezomib and rituximab for Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation [Phase 2]
This Phase 2 trial evaluates adding amifostine to chemotherapy versus chemotherapy alone in patients with recurrent or refractory non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide [Phase 1]
Phase 1 trial evaluating Rituximab with Ifosfamide, Carboplatin, and Etoposide for Non-Hodgkin lymphoma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating cyclophosphamide, doxorubicin, vincristine, and prednisone with or without gemcitabine in patients with previously …
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating combination chemotherapy in older patients with Non-Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating combination chemotherapy with or without etoposide in older patients with Non-Hodgkin's lymphoma was t…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating PS-341 (bortezomib) alone and with EPOCH chemotherapy for Non-Hodgkin lymphoma; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of CAL-101 in relapsed or refractory hematologic malignancies has completed, evaluating safety and preliminary…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology [Phase 2]
Phase 2 study evaluating an iodine-131 labeled anti-B1 antibody for first or second relapse indolent B-cell non-Hodgkin lymphoma and lymphom…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated CD8 donor lymphocyte infusion for relapse or residual disease after allogeneic stem cell transplantation. The …
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Tositumomab with I-131-tositumomab in patients with relapsed indolent non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood [Phase 2]
This entry summarizes a Phase 2 trial evaluating low-intensity conditioning followed by allogeneic stem cell transplantation for patients wi…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma [Phase 3]
An update on a Phase 3 safety and efficacy study of bendamustine for non-Hodgkin lymphoma, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update examining influenza vaccination in patients with Non-Hodgkin lymphoma receiving antineoplastic therapy; the study has c…
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: Rituximab Maintenance After Autologous Transplantation [Phase 3]
A Phase 3 trial evaluating rituximab maintenance after autologous transplantation in non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers [Phase 2]
Phase II trial of ZIO-101 for advanced blood and bone marrow cancers has completed, sponsored by Alaunos Therapeutics.
-
CLINICAL_TRIALS research · 2012-07-19Clinical Trial Update: Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]
This is a Phase I clinical trial update of oral darinaparsin (ZIO-101-C) in patients with advanced solid tumors and Non-Hodgkin lymphoma; no…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating weekly SAR3419 in relapsed/refractory CD19-positive B-cell non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating involved-field radiation therapy for previously untreated stage I/II low-grade non-Hodgkin's lymphoma was terminate…
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas [Phase 2]
This trial update notes the completion of Phase II evaluation of the Gemcitabine–Rituximab–Oxaliplatin (GROC) regimen in relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 clinical trial compares adding Zevalin to BEAM high-dose chemotherapy versus BEAM conditioning alone in chemosensitive relapsed no…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL) [Phase 1, Phase 2]
This update summarizes Phase 1/2 trial results for clo farabine in relapsed or refractory T-cell or B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…